Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Adlai Nortye Ltd.
ANL | US
12.06
USD0.90
8.06%
ANL | US
About Adlai Nortye Ltd.
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
13/04/2026
Close
12.06
Open
12.08
High
13.00
Low
10.81
View Less
ANL | US
Risk
120.1
Sharpe
3.50
Luna's Score
63/100
Recommendation
Hold
Luna says (ANL | US)
What's Working
Positive Momentum
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
What's not Working
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
Weak Operating Margin (< 10%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
129.6%1 month
120.1%3 months
241.1%6 months
189.7%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.35
Debt to equity
0.73
Debt to assets
0.36
Ent. to EBITDA
-
Ent. to rev.
2.70
PEG
-
Other Fundamentals
EBITDA
-63.57M
MarketCap
445.02M
MarketCap(USD)
445.02M
Div. yield
-
Op. margin
-1.29K
Erngs. growth
-
Rev. growth
-
Ret. on equity
-
Short ratio
0.72
Short perc.
0.03
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
6.66
Range1M
6.66
Range3M
11.52
Volumes: Market Activity
Rel. volume
2.25
Price X volume
9.86M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | - | - | - |
| Ent. to Revenue | 2.70 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 1.35 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 241.12 | - | Riskier |
| Debt to Equity | 0.73 | -1.23 | Expensive |
| Debt to Assets | 0.36 | 0.25 | Expensive |
| Market Cap | 445.02M | - | Emerging |
